Advertisement
Review Article| Volume 3, ISSUE 1, P375-387, August 2018

Download started.

Ok

Autoimmune Retinopathy

Challenges in Diagnosis and Management
  • Saghar Bagheri
    Affiliations
    Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, 243 Charles Street, 12th Floor, Boston, MA 02114, USA
    Search for articles by this author
  • Lucia Sobrin
    Correspondence
    Corresponding author. Uveitis Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, 243 Charles Street, 12th Floor, Boston, MA 02114.
    Affiliations
    Retina Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, 243 Charles Street, 12th Floor, Boston, MA 02114, USA

    Uveitis Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, 243 Charles Street, 12th Floor, Boston, MA 02114, USA
    Search for articles by this author
      Presence of antiretinal antibodies alone does not establish the diagnosis of autoimmune retinopathy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Ophthalmology and Optometry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Diagnosis and Management of Autoimmune Retinopathy. American Academy of Ophthalmology. 2017. Available at: https://www.aao.org/eyenet/article/diagnosis-and-management-of-autoimmune-retinopathy. Accessed October 29, 2017.

        • Grange L.
        • Dalal M.
        • Nussenblatt R.B.
        • et al.
        Autoimmune retinopathy.
        Am J Ophthalmol. 2014; 157: 266-272.e1
        • Ten Berge J.C.
        • van Rosmalen J.
        • Vermeer J.
        • et al.
        Serum autoantibody profiling of patients with paraneoplastic and non-paraneoplastic autoimmune retinopathy.
        PLoS One. 2016; 11: e0167909
        • Grewal D.S.
        • Fishman G.A.
        • Jampol L.M.
        Autoimmune retinopathy and antiretinal antibodies: a review.
        Retina. 2014; 34: 827-845
        • Braithwaite T.
        • Vugler A.
        • Tufail A.
        Autoimmune retinopathy.
        Ophthalmologica. 2012; 228: 131-142
        • Shildkrot Y.
        • Sobrin L.
        • Gragoudas E.S.
        Cancer-associated retinopathy: update on pathogenesis and therapy.
        Semin Ophthalmol. 2011; 26: 321-328
        • Fox A.R.
        • Gordon L.K.
        • Heckenlively J.R.
        • et al.
        Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified Delphi approach.
        Am J Ophthalmol. 2016; 168: 183-190
        • Heckenlively J.R.
        • Aptsiauri N.
        • Nusinowitz S.
        • et al.
        Investigations of antiretinal antibodies in pigmentary retinopathy and other retinal degenerations.
        Trans Am Ophthalmol Soc. 1996; 94 ([discussion: 200–6]): 179-200
        • Penfold P.L.
        • Madigan M.C.
        • Gillies M.C.
        • et al.
        Immunological and aetiological aspects of macular degeneration.
        Prog Retin Eye Res. 2001; 20: 385-414
        • Patel N.
        • Ohbayashi M.
        • Nugent A.K.
        • et al.
        Circulating anti-retinal antibodies as immune markers in age-related macular degeneration.
        Immunology. 2005; 115: 422-430
        • Faez S.
        • Loewenstein J.
        • Sobrin L.
        Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy.
        JAMA Ophthalmol. 2013; 131: 113-115
        • Heckenlively J.R.
        • Fawzi A.A.
        • Oversier J.
        • et al.
        Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration.
        Arch Ophthalmol. 2000; 118: 1525-1533
        • Heckenlively J.R.
        • Jordan B.L.
        • Aptsiauri N.
        Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa.
        Am J Ophthalmol. 1999; 127: 565-573
        • Mahdi N.
        • Faia L.J.
        • Goodwin J.
        • et al.
        A case of autoimmune retinopathy associated with thyroid carcinoma.
        Ocul Immunol Inflamm. 2010; 18: 322-323
        • Dy I.
        • Chintapatla R.
        • Preeshagul I.
        • et al.
        Treatment of cancer-associated retinopathy with rituximab.
        J Natl Compr Canc Netw. 2013; 11: 1320-1324
        • Fox A.
        • Jeffrey B.
        • Hasni S.
        • et al.
        Rituximab treatment for nonparaneoplastic autoimmune retinopathy.
        Can J Ophthalmol. 2015; 50: e101-e104
        • Huynh N.
        • Shildkrot Y.
        • Lobo A.-M.
        • et al.
        Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy.
        J Ophthalmic Inflamm Infect. 2012; 2: 169-171
        • Guy J.
        • Aptsiauri N.
        Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
        Arch Ophthalmol. 1999; 117: 471-477
        • Davoudi S.
        • Ebrahimiadib N.
        • Yasa C.
        • et al.
        Outcomes in autoimmune retinopathy patients treated with rituximab.
        Am J Ophthalmol. 2017; 180: 124-132
        • Ferreyra H.A.
        • Jayasundera T.
        • Khan N.W.
        • et al.
        Management of autoimmune retinopathies with immunosuppression.
        Arch Ophthalmol. 2009; 127: 390-397
        • Murphy M.A.
        • Thirkill C.E.
        • Hart W.M.
        Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma.
        J Neuroophthalmol. 1997; 17: 77-83
        • Hooks J.J.
        • Tso M.O.
        • Detrick B.
        Retinopathies associated with antiretinal antibodies.
        Clin Diagn Lab Immunol. 2001; 8: 853-858
        • Shimazaki K.
        • Jirawuthiworavong G.V.
        • Heckenlively J.R.
        • et al.
        Frequency of anti-retinal antibodies in normal human serum.
        J Neuroophthalmol. 2008; 28: 5-11
        • Qian C.X.
        • Wang A.
        • DeMill D.L.
        • et al.
        Prevalence of antiretinal antibodies in acute zonal occult outer retinopathy: a comprehensive review of 25 cases.
        Am J Ophthalmol. 2017; 176: 210-218
        • Heckenlively J.R.
        • Ferreyra H.A.
        Autoimmune retinopathy: a review and summary.
        Semin Immunopathol. 2008; 30: 127-134
        • Zhu L.
        • Shen W.
        • Zhu M.
        • et al.
        Anti-retinal antibodies in patients with macular telangiectasia type 2.
        Invest Ophthalmol Vis Sci. 2013; 54: 5675-5683
        • Bujakowska K.M.
        • Fernandez-Godino R.
        • Place E.
        • et al.
        Copy-number variation is an important contributor to the genetic causality of inherited retinal degenerations.
        Genet Med. 2017; 19: 643-651
        • Lu Y.
        • He S.
        • Jia L.
        • et al.
        Two mouse models for recoverin-associated autoimmune retinopathy.
        Mol Vis. 2010; 16: 1936-1948
        • Davoudi S.
        • Ahmadi T.
        • Papavasilieou E.
        • et al.
        Phage immunoprecipitation sequencing of autoantigens in autoimmune retinopathy.
        Ocul Immunol Inflamm. 2018; 26: 417-424
        • Stansky E.
        • Biancotto A.
        • Dagur P.K.
        • et al.
        B cell anomalies in autoimmune retinopathy (AIR).
        Invest Ophthalmol Vis Sci. 2017; 58: 3600-3607
        • Boudreault K.
        • Justus S.
        • Sengillo J.D.
        • et al.
        Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy.
        Orphanet J Rare Dis. 2017; 12: 129
        • Maleki A.
        • Lamba N.
        • Ma L.
        • et al.
        Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy.
        Clin Ophthalmol. 2017; 11: 377-385
        • Keltner J.L.
        • Thirkill C.E.
        • Tyler N.K.
        • et al.
        Management and monitoring of cancer-associated retinopathy.
        Arch Ophthalmol. 1992; 110: 48-53
        • Larman H.B.
        • Laserson U.
        • Querol L.
        • et al.
        PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis.
        J Autoimmun. 2013; 43: 1-9
        • Xu G.J.
        • Shah A.A.
        • Li M.Z.
        • et al.
        Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer.
        Proc Natl Acad Sci U S A. 2016; 113: E7526-E7534
        • Dot C.
        • Guigay J.
        • Adamus G.
        Anti-alpha-enolase antibodies in cancer-associated retinopathy with small cell carcinoma of the lung.
        Am J Ophthalmol. 2005; 139: 746-747